Ylva Ginsberg

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Leg. läkare 1994, specialistläkare i psykiatri 1999.
Doktor i medicinsk vetenskap 2012 vid Karolinska Institutet, Institutionen
för klinisk neurovetenskap, Centrum för psykiatriforskning.
Avhandlingens titel: Attention deficit hyperactivity disorder in prison
inmates: http://publications.ki.se/xmlui/handle/10616/41012.

Forskningsbeskrivning

Forskningen rör olika aspekter av ADHD, inklusive samsjuklighet och
innefattar såväl kliniknära studier som undersökningar med hjälp
av befolkningsbaserade register.
Jag är anknuten som postdoktoral forskare i docent Yvonne von
Hausswolff-Juhlins forskargrupp för klinisk ätstörningsforskning vid
Institutionen för klinisk neurovetenskap/Centrum för psykiatriforskning,

Artiklar

Article: JOURNAL OF ATTENTION DISORDERS. 2023;27(12):1309-1321

Epidemiology, Treatment Patterns, Comorbidities, and Concomitant Medication in Patients with ADHD in Sweden: A Registry-Based Study (2018-2021).

Giacobini M; Ahnemark E; Medin E; Freilich J; Andersson M; Ma Y; Ginsberg Y
Article: BRITISH JOURNAL OF PSYCHIATRY. 2023;222(1):7-17

Randomised controlled trial of the short-term effects of osmotic-release oral system methylphenidate on symptoms and behavioural outcomes in young male prisoners with attention deficit hyperactivity disorder: CIAO-II study.

Asherson PJ; Johansson L; Holland R; Bedding M; Forrester A; Giannulli L; Ginsberg Y; Howitt S; Kretzschmar I; Lawrie SM; Marsh C; Kelly C; Mansfield M; McCafferty C; Khan K; Müller-Sedgwick U; Strang J; Williamson G; Wilson L; Young S; Landau S; Thomson LDG
Article: BMC PSYCHIATRY. 2022;22(1):751

Stress and work-related mental illness among working adults with ADHD: a qualitative study.

Oscarsson M; Nelson M; Rozental A; Ginsberg Y; Carlbring P; Jönsson F
Article: JOURNAL OF PATIENT-REPORTED OUTCOMES. 2022;6(1):45

Evidence for validity of the Swedish self-rated 36-item version of the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) in patients with mental disorders: a multi-centre cross-sectional study using Rasch analysis.

Svanborg C; Amer A; Nordenskjöld A; Ramklint M; Söderberg P; Tungström S; Ginsberg Y; Hermansson L
Article: NORDIC JOURNAL OF PSYCHIATRY. 2021;75(7):494-501

Psychometric evaluation of the Swedish self-rated 36-item version of WHODAS 2.0 for use in psychiatric populations - using classical test theory.

Midhage R; Hermansson L; Söderberg P; Tungström S; Nordenskjöld A; Svanborg C; Ginsberg Y; Ramklint M
Article: BMC PSYCHIATRY. 2021;21(1):226

Prevalence of criminal convictions in Norwegian adult ADHD outpatients and associations with ADHD symptom severity and emotional dysregulation.

Anker E; Ginsberg Y; Heir T
Article: EUROPEAN EATING DISORDERS REVIEW. 2021;29(1):133-143

Are attention deficit hyperactivity disorder symptoms stable irrespective of recovery from eating disorders? A 1-year follow-up of adult females.

Svedlund NE; Norring C; Ginsberg Y; von Hausswolff-Juhlin Y
Article: JOURNAL OF ATTENTION DISORDERS. 2020;24(6):904-917

Group Treatment for Adults With ADHD Based on a Novel Combination of Cognitive and Dialectical Behavior Interventions: A Feasibility Study.

Nasri B; Castenfors M; Fredlund P; Ginsberg Y; Lindefors N; Kaldo V
Article: TRIALS. 2020;21(1):161

Treating impulsivity with probiotics in adults (PROBIA): study protocol of a multicenter, double-blind, randomized, placebo-controlled trial.

Arteaga-Henríquez G; Rosales-Ortiz SK; Arias-Vásquez A; Bitter I; Ginsberg Y; Ibañez-Jimenez P; Kilencz T; Lavebratt C; Matura S; Reif A; Rethelyi J; Richarte V; Rommelse N; Siegl A; Ramos-Quiroga JA
Article: EUROPEAN PSYCHIATRY. 2019;56:14-34

Updated European Consensus Statement on diagnosis and treatment of adult ADHD.

Kooij JJS; Bijlenga D; Salerno L; Jaeschke R; Bitter I; Balázs J; Thome J; Dom G; Kasper S; Nunes Filipe C; Stes S; Mohr P; Leppämäki S; Casas M; Bobes J; Mccarthy JM; Richarte V; Kjems Philipsen A; Pehlivanidis A; Niemela A; Styr B; Semerci B; Bolea-Alamanac B; Edvinsson D; Baeyens D; Wynchank D; Sobanski E; Philipsen A; McNicholas F; Caci H; Mihailescu I; Manor I; Dobrescu I; Saito T; Krause J; Fayyad J; Ramos-Quiroga JA; Foeken K; Rad F; Adamou M; Ohlmeier M; Fitzgerald M; Gill M; Lensing M; Motavalli Mukaddes N; Brudkiewicz P; Gustafsson P; Tani P; Oswald P; Carpentier PJ; De Rossi P; Delorme R; Markovska Simoska S; Pallanti S; Young S; Bejerot S; Lehtonen T; Kustow J; Müller-Sedgwick U; Hirvikoski T; Pironti V; Ginsberg Y; Félegyházy Z; Garcia-Portilla MP; Asherson P
Article: JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY. 2019;60(2):160-168

Maternal infection requiring hospitalization during pregnancy and attention-deficit hyperactivity disorder in offspring: a quasi-experimental family-based study.

Ginsberg Y; D'Onofrio BM; Rickert ME; Class QA; Rosenqvist MA; Almqvist C; Lichtenstein P; Larsson H
Article: BMC PSYCHIATRY. 2018;18(1):223

Health-related quality of life and burden of illness in adults with newly diagnosed attention-deficit/hyperactivity disorder in Sweden.

Ahnemark E; Di Schiena M; Fredman A-C; Medin E; Söderling JK; Ginsberg Y
Article: EUROPEAN EATING DISORDERS REVIEW. 2018;26(4):337-345

Are treatment results for eating disorders affected by ADHD symptoms? A one-year follow-up of adult females.

Svedlund NE; Norring C; Ginsberg Y; von Hausswolff-Juhlin Y
Article: NEUROPSYCHIATRIC DISEASE AND TREATMENT. 2018;14:1149-1161

Estimated prevalence and incidence of diagnosed ADHD and health care utilization in adults in Sweden - a longitudinal population-based register study.

Polyzoi M; Ahnemark E; Medin E; Ginsberg Y
Article: BMC PSYCHIATRY. 2017;17(1):19

Symptoms of Attention Deficit Hyperactivity Disorder (ADHD) among adult eating disorder patients.

Svedlund NE; Norring C; Ginsberg Y; von Hausswolff-Juhlin Y
Article: JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY. 2015;35(5):535-543

Long-Term Treatment Outcome in Adult Male Prisoners With Attention-Deficit/Hyperactivity Disorder: Three-Year Naturalistic Follow-Up of a 52-Week Methylphenidate Trial.

Ginsberg Y; Långström N; Larsson H; Lindefors N
Article: CNS DRUGS. 2014;28(10):951-962

Long-term (1 year) safety and efficacy of methylphenidate modified-release long-acting formulation (MPH-LA) in adults with attention-deficit hyperactivity disorder: a 26-week, flexible-dose, open-label extension to a 40-week, double-blind, randomised, placebo-controlled core study.

Ginsberg Y; Arngrim T; Philipsen A; Gandhi P; Chen C-W; Kumar V; Huss M
Article: CLINICAL DRUG INVESTIGATION. 2014;34(9):639-649

Open-label dose optimization of methylphenidate modified release long acting (MPH-LA): a post hoc analysis of real-life titration from a 40-week randomized trial.

Huss M; Ginsberg Y; Arngrim T; Philipsen A; Carter K; Chen C-W; Gandhi P; Kumar V
Article: THE PRIMARY CARE COMPANION FOR CNS DISORDERS. 2014;16(3):PCC.13r01600

Underdiagnosis of attention-deficit/hyperactivity disorder in adult patients: a review of the literature.

Ginsberg Y; Quintero J; Anand E; Casillas M; Upadhyaya HP
Article: ADVANCES IN THERAPY. 2014;31(1):44-65

Methylphenidate hydrochloride modified-release in adults with attention deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial.

Huss M; Ginsberg Y; Tvedten T; Arngrim T; Philipsen A; Carter K; Chen C-W; Kumar V
Article: WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY. 2013;14(4):268-281

Efficacy and safety of prolonged-release OROS methylphenidate in adults with attention deficit/hyperactivity disorder: a 13-week, randomized, double-blind, placebo-controlled, fixed-dose study.

Casas M; Rösler M; Sandra Kooij JJ; Ginsberg Y; Ramos-Quiroga JA; Heger S; Berwaerts J; Dejonckheere J; van der Vorst E; Schäuble B
Article: WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY. 2013;14(4):282-290

Correlation of symptomatic improvements with functional improvements and patient-reported outcomes in adults with attention-deficit/hyperactivity disorder treated with OROS methylphenidate.

Rösler M; Ginsberg Y; Arngrim T; Adamou M; Niemelä A; Dejonkheere J; van Oene J; Schäuble B
Article: EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 2012;262(8):705-724

Long-term functional outcome in adult prison inmates with ADHD receiving OROS-methylphenidate.

Ginsberg Y; Hirvikoski T; Grann M; Lindefors N
Article: BRITISH JOURNAL OF PSYCHIATRY. 2012;200(1):68-73

Methylphenidate treatment of adult male prison inmates with attention-deficit hyperactivity disorder: randomised double-blind placebo-controlled trial with open-label extension.

Ginsberg Y; Lindefors N
Article: BMC PSYCHIATRY. 2010;10:112

Attention Deficit Hyperactivity Disorder (ADHD) among longer-term prison inmates is a prevalent, persistent and disabling disorder.

Ginsberg Y; Hirvikoski T; Lindefors N
Article: LAKARTIDNINGEN. 2007;104(18):1398-1400

[ADHD difficult to diagnose in adults. ASRS v1.1 Self-Report Scales valuable help--now translated to Swedish].

Rodriguez A; Ginsberg Y; Fernholm A; Nyberg L
Visa fler

Alla övriga publikationer

Review: LAKARTIDNINGEN. 2022;119:21105

[The dark side of ADHD - comorbidity with substance use disorder and criminality - an overview].

Johansson Capusan A; Guterstam J; Ginsberg Y; Borg Skoglund L
Review: NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2022;132:1157-1180

Non-mental diseases associated with ADHD across the lifespan: Fidgety Philipp and Pippi Longstocking at risk of multimorbidity?

Kittel-Schneider S; Arteaga-Henriquez G; Vasquez AA; Asherson P; Banaschewski T; Brikell I; Buitelaar J; Cormand B; Faraone SV; Freitag CM; Ginsberg Y; Haavik J; Hartman CA; Kuntsi J; Larsson H; Matura S; McNeill RV; Ramos-Quiroga JA; Ribases M; Romanos M; Vainieri I; Franke B; Reif A
Review: NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2021;120:236-248

Attention-Deficit/Hyperactivity Disorder (ADHD), antisociality and delinquent behavior over the lifespan.

Retz W; Ginsberg Y; Turner D; Barra S; Retz-Junginger P; Larsson H; Asherson P
Review: LAKARTIDNINGEN. 2019;116:FMUT

[Treatment of eating disorders with concurrent ADHD symptoms: knowledge, knowledge gaps and clinical implications].

Svedlund NE; Norring C; Ginsberg Y; von Hausswolff-Juhlin Y
Review: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2018;28(10):1059-1088

Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan.

Franke B; Michelini G; Asherson P; Banaschewski T; Bilbow A; Buitelaar JK; Cormand B; Faraone SV; Ginsberg Y; Haavik J; Kuntsi J; Larsson H; Lesch K-P; Ramos-Quiroga JA; Réthelyi JM; Ribases M; Reif A
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2014;24:S709

Prevalence and treatment patterns of adults with newly diagnosed attention-deficit/hyperactivity disorder in Sweden

Ginsberg Y; Medin E; Ahnemark E; Carlqvist P
Review: EXPERT REVIEW OF NEUROTHERAPEUTICS. 2014;14(7):799-812

The unmet needs of all adults with ADHD are not the same: a focus on Europe.

Ginsberg Y; Beusterien KM; Amos K; Jousselin C; Asherson P
Editorial comment: EXPERT REVIEW OF NEUROTHERAPEUTICS. 2013;13(4):345-348

ADHD and criminality: could treatment benefit prisoners with ADHD who are at higher risk of reoffending?

Ginsberg Y; Långström N; Larsson H; Lichtenstein P
KI thesis / dissertation: 2012

Attention deficit hyperactivity disorder in prison inmates

Ginsberg, Ylva
Review: BMC PSYCHIATRY. 2010;10:67

European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD.

Kooij SJJ; Bejerot S; Blackwell A; Caci H; Casas-Brugué M; Carpentier PJ; Edvinsson D; Fayyad J; Foeken K; Fitzgerald M; Gaillac V; Ginsberg Y; Henry C; Krause J; Lensing MB; Manor I; Niederhofer H; Nunes-Filipe C; Ohlmeier MD; Oswald P; Pallanti S; Pehlivanidis A; Ramos-Quiroga JA; Rastam M; Ryffel-Rawak D; Stes S; Asherson P

Anställningar

Anknuten till Forskning, Klinisk neurovetenskap, Karolinska Institutet, 2023-2025

Examina och utbildning

Medicine Doktorsexamen, Institutionen för klinisk neurovetenskap, Karolinska Institutet, 2012
Läkarexamen, Karolinska Institutet, 1990

Om mig

Forskningsbeskrivning

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI